Showing results (231-240 of 320) with videos related to

Sort By:
Pageof 32
Molecular Cancer Therapeutics|March 5, 2009
Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expressionSanthi Konduri, Jimmie Colon, Cheryl H Baker, et al.
Drug Delivery and Translational Research|July 14, 2016
Lipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluationCedar H A Boakye, Ketan Patel, Apurva R Patel, et al.
Molecular Cancer Therapeutics|May 4, 2012
Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancerXinyi Liu, Indira Jutooru, Ping Lei, et al.
Molecular Cancer Therapeutics|July 23, 2008
5,5'-Dibromo-bis(3'-indolyl)methane induces Kruppel-like factor 4 and p21 in colon cancer cellsSung Dae Cho, Sudhakar Chintharlapalli, Maen Abdelrahim, et al.
Molecular Carcinogenesis|October 25, 2007
1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cellsSung Dae Cho, Ping Lei, Maen Abdelrahim, et al.
Toxicology and Applied Pharmacology|March 23, 2011
Multiphoton spectral analysis of benzo[a]pyrene uptake and metabolism in a rat liver cell lineRola Barhoumi, Youssef Mouneimne, Ernesto Ramos, et al.
International Journal of Molecular Sciences|May 7, 2025
Expression of Prooncogenic Nuclear Receptor 4A (NR4A)-Regulated Genes β1-Integrin and G9a Inhibited by Dual NR4A1/2 LigandsLei Zhang, Victoria Gatlin, Shreyan Gupta, et al.
Molecular Carcinogenesis|January 27, 2011
Inhibition of pituitary tumor-transforming gene-1 in thyroid cancer cells by drugs that decrease specificity proteinsSudhakar Chintharlapalli, Sabitha Papineni, Syng-Ook Lee, et al.
Pageof 32